Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying

Published 27/12/2022, 11:12
© Reuters.  Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying
IXIC
-
CPIX
-
ERAS
-

Benzinga - The Dow Jones settled higher by around 175 points on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Erasca

  • The Trade: Erasca, Inc. (NASDAQ: ERAS) Director Arthur James Bristol bought a total of 20,000 shares at an average price of $4.14. To acquire these shares, it cost around $82.8 thousand.
  • What’s Happening: Erasca said first patient was dosed in HERKULES-1 Phase 1b trial evaluating ERAS-007 and ERAS-601 MAPKlamp combination in RAS/MAPK pathway-altered solid tumors.
  • What Erasca Does: Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Cumberland Pharmaceuticals

  • The Trade: Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) Director Kenneth Krogulski acquired a total of 3,050 shares at an average price of $2.22. The insider spent around $6.78 thousand to buy those shares.
  • What’s Happening: Cumberland Pharmaceuticals, last month, posted a profit for its third quarter.
  • What Cumberland Pharmaceuticals Does: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products.

Don’t forget to check out our premarket coverage here

Red Cat Holdings

  • The Trade: Red Cat Holdings, Inc. (NASDAQ: RCAT) Director, Chairman of the Board, CEO Jeffrey M Thompson acquired a total of 3,300 shares at an average price of $0.79. To acquire these shares, it cost around $2.61 thousand.
  • What’s Happening: Red Cat recently reported wider-than-expected quarterly loss.
  • What Red Cat Holdings Does: Red Cat Holdings Inc provides products, services, and solutions to the drone industry. It offers First Person View (FPV) video goggles to the drone industry, sells FPV drones and equipment, and provides various software and hardware solutions.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.